Ainos launches NTU breath-analysis research program for ER dyspnea
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/20/2026
- Wall Street indexes fall, with Iran and earnings season in focus
- Oil settles 1% higher as hopes of renewed US-Iran negotiations offset Houthi threat
- Selloff of U.S. memory stocks creates a compelling entry point: analyst
- Why Moonshot AI's Kimi K3 is actually bullish for memory stocks
- AMC Entertainment soars on record quarterly results
- U.S. to impose 50% tariff on most Canadian goods, including USMCA
- Cantor Fitzgerald Starts Trulieve Cannabis (TRLV) at Overweight, 'Purpose-Built for a New Cannabis Regulatory Framework'
- Wall Street indexes fall, with Iran and earnings season in focus
- Selloff of U.S. memory stocks creates a compelling entry point: analyst
- NVIDIA reports 9.3% passive stake in Nebius
Ainos Expands Smell AI Platform into Digital Breath Intelligence Through National Taiwan University Research Program
June 17, 2026 8:01 AM EDTProgram expands Ainos' Smell AI platform from environmental intelligence into digital breath intelligence for emergency medicine research
HOUSTON, TX / ACCESS Newswire / June 17, 2026 / Ainos, Inc. (NASDAQ: AIMD)(NASDAQ: AIMDW) ("Ainos" or the "Company"), a pioneer in AI-powered scent digitization and Smell AI technologies, today announced a new research program with National Taiwan University ("NTU") to explore the use of Smell AI in emergency medicine.
The program, titled "Rapid Diagnosis of Dyspneic Patients... More
